{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T20:05:56Z","timestamp":1757621156102,"version":"3.44.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T00:00:00Z","timestamp":1754092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T00:00:00Z","timestamp":1754092800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Dutch Ministry of Health, Welfare and Sports","award":["324366","324366","324366","324366","324366","324366"],"award-info":[{"award-number":["324366","324366","324366","324366","324366","324366"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Geriatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Psychotropic drugs are modestly effective and may cause adverse effects. Efforts to reduce inappropriateness and increase usage of psychosocial interventions often suffer from suboptimal implementation. The purpose of this study was to evaluate effectiveness of an innovative study using implementation promoting elements in nursing home residents with dementia and neuropsychiatric symptoms.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A multicenter cluster randomized controlled trial with a special case of a stepped-wedge design with two arms and one stap was designed. The intervention comprised participatory action research, tailored information provision and external coaching, leading to the implementation of tailored action and implementation plans. The primary outcome was inappropriateness of psychotropic drug use (Appropriate Psychotropic Drug Use in Dementia [APID] index) and the secondary outcome was percentage of psychotropic drug use at baseline, 8 months, and 16 months. Homes were allocated to start with usual care or the intervention. After 8 months, the control group crossed over to receive the intervention. The other homes continued the intervention to 16 months. Patients were eligible if they were diagnosed with dementia, had a life expectancy of at least 3 months, and resided in psychogeriatric units.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>An adjusted multilevel model revealed no effect on the APID index sum score at 8 months (0.564; 95% confidence interval [CI], -2.449\u20133.577; <jats:italic>p<\/jats:italic>\u2009=\u20090.71) or 16 months (2.165; 95% CI, -1.113\u20135.443; <jats:italic>p<\/jats:italic>\u2009=\u20090.20). An adjusted generalized estimation equation (GEE) model showed an effect at 16 months for percentage of use (OR 0.654; 95% CI, 0.481\u20130.889; <jats:italic>p<\/jats:italic>\u2009=\u20090.007). Adjusted GEE models showed an effect especially at 16 months for anxiolytics (OR 0.573; 95% CI, 0.382\u20130.859; <jats:italic>p<\/jats:italic>\u2009=\u20090.007) and antidepressants (OR 0.678; 95% CI, 0.475\u20130.968; <jats:italic>p<\/jats:italic>\u2009=\u20090.033).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>No reduction of inappropriateness was found although overall usage was reduced. Professionals focused on implementing alternatives to compensate for usage, rather than prescribing quality. Future studies may focus on changing physicians\u2019 prescribing behaviors in combination with multicomponent and multidisciplinary psychosocial alternatives.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Trial registration<\/jats:title>\n            <jats:p>Netherlands Trial Registry (NTR5872) on 27\/05\/2016, <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/onderzoekmetmensen.nl\/nl\/node\/26060\/pdf\" ext-link-type=\"uri\">https:\/\/onderzoekmetmensen.nl\/nl\/node\/26060\/pdf<\/jats:ext-link>.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12877-025-06206-y","type":"journal-article","created":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T13:26:04Z","timestamp":1754141164000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tailored interventions for inappropriate psychotropic drug use in nursing home residents with dementia: participatory action research in a special case of a stepped-wedge cluster randomized controlled trial"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4680-0738","authenticated-orcid":false,"given":"Claudia M. Groot","family":"Kormelinck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debby L.","family":"Gerritsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte F.","family":"van Teunenbroek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiel R.","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Smalbrugge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sytse U.","family":"Zuidema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,2]]},"reference":[{"key":"6206_CR1","unstructured":"World Health Organization. Dementia [Internet]. 2023 [cited 2023 Apr 4]. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/dementia."},{"issue":"7","key":"6206_CR2","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1002\/gps.1722","volume":"22","author":"SU Zuidema","year":"2007","unstructured":"Zuidema SU, Derksen E, Verhey FRJ, Koopmans RTCM. Prevalence of neuropsychiatric symptoms in a large sample of Dutch nursing home patients with dementia. Int J Geriatr Psychiatry. 2007;22(7):632\u20138.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"3","key":"6206_CR3","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jamda.2012.09.027","volume":"14","author":"G Selb\u00e6k","year":"2013","unstructured":"Selb\u00e6k G, Engedal K, Bergh S. The prevalence and course of neuropsychiatric symptoms in nursing home patients with dementia: A systematic review. J Am Med Dir Assoc. 2013;14(3):161\u20139.","journal-title":"J Am Med Dir Assoc"},{"key":"6206_CR4","doi-asserted-by":"crossref","unstructured":"Johnell K, Jonasdottir Bergman G, Fastbom J, Danielsson B, Borg N, Salmi P. Psychotropic drugs and the risk of fall injuries, hospitalisations and mortality among older adults. Int J Geriatr Psychiatry. 2017;32(4):414\u201320.","DOI":"10.1002\/gps.4483"},{"key":"6206_CR5","doi-asserted-by":"crossref","unstructured":"Taipale H, Koponen M, Tanskanen A, Lavikainen P, Tolppanen AM, Sund R, et al. Use of benzodiazepines and related drugs is associated with a risk of stroke among persons with alzheimer\u2019s disease. Int Clin Psychopharmacol. 2017;32(3):135\u201341.","DOI":"10.1097\/YIC.0000000000000161"},{"key":"6206_CR6","doi-asserted-by":"crossref","unstructured":"Koponen M, Taipale H, Lavikainen P, Tanskanen A, Tiihonen J, Tolppanen AM, et al. Risk of mortality associated with antipsychotic monotherapy and polypharmacy among community-dwelling persons with alzheimer\u2019s disease. J Alzheimer\u2019s Disease. 2017;56(1):107\u201318.","DOI":"10.3233\/JAD-160671"},{"key":"6206_CR7","unstructured":"Zuidema SU, van Iersel MB, Koopmans RTCM, Verhey FRJ, Olde Rikkert MGM. Efficacy and adverse reactions of antipsychotics for neuropsychiatric symptoms in dementia: a systematic review. Ned Tijdschr Geneeskd. 2006;150(28):1565\u201373."},{"key":"6206_CR8","unstructured":"Zuidema SU, Smalbrugge M, Verenso. 2018 [cited 2022 Sep 9]. Probleemgedrag bij mensen met dementie: Problem behavior in people with dementia. Available from: https:\/\/www.verenso.nl\/richtlijnen-en-praktijkvoering\/richtlijnendatabase\/probleemgedrag-bij-mensen-met-dementie."},{"key":"6206_CR9","doi-asserted-by":"crossref","unstructured":"Seitz DP, Gill SS, Herrmann N, Brisbin S, Rapoport MJ, Rines J, et al. Pharmacological treatments for neuropsychiatric symptoms of dementia in long-term care: A systematic review. Int Psychogeriatr. 2013;25(2):185\u2013203.","DOI":"10.1017\/S1041610212001627"},{"key":"6206_CR10","doi-asserted-by":"crossref","unstructured":"Ballard CG, Waite J, Birks J. The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer\u2019s disease. Cochrane Database Syst Reviews. 2006;2006(1):CD003476.","DOI":"10.1002\/14651858.CD003476.pub2"},{"issue":"10248","key":"6206_CR11","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","volume":"396","author":"G Livingston","year":"2020","unstructured":"Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, et al. Dementia prevention, intervention, and care: 2020 report of the lancet commission. Lancet. 2020;396(10248):413\u201346.","journal-title":"Lancet"},{"issue":"3","key":"6206_CR12","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1017\/S1041610217001788","volume":"30","author":"G Selb\u00e6k","year":"2018","unstructured":"Selb\u00e6k G, Janus SIM, Bergh S, Engedal K, Ruths S, Helvik AS, et al. Change in psychotropic drug use in Norwegian nursing homes between 2004 and 2011. Int Psychogeriatr. 2018;30(3):385\u201394.","journal-title":"Int Psychogeriatr"},{"key":"6206_CR13","doi-asserted-by":"crossref","unstructured":"Du J, Janus S, Voorthuis B, van Manen J, Achterberg W, Smalbrugge M, et al. Time trends in psychotropic drug prescriptions in Dutch nursing home residents with dementia between 2003 and 2018. Int J Geriatr Psychiatry. 2022;37(4):1\u201310.","DOI":"10.1002\/gps.5697"},{"issue":"2","key":"6206_CR14","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1177\/0004867418758919","volume":"53","author":"J Westbury","year":"2019","unstructured":"Westbury J, Gee P, Ling T, Kitsos A, Peterson G. More action needed: psychotropic prescribing in Australian residential aged care. Aust N Z J Psychiatry. 2019;53(2):136\u201347.","journal-title":"Aust N Z J Psychiatry"},{"issue":"8","key":"6206_CR15","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1017\/S1041610211000755","volume":"23","author":"RB Wetzels","year":"2011","unstructured":"Wetzels RB, Zuidema SU, de Jonghe JF, Verhey FR, Koopmans RT. Prescribing pattern of psychotropic drugs in nursing home residents with dementia. Int Psychogeriatr. 2011;23(8):1249\u201359.","journal-title":"Int Psychogeriatr"},{"issue":"11","key":"6206_CR16","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1017\/S1041610216001150","volume":"28","author":"SIM Janus","year":"2016","unstructured":"Janus SIM, van Manen JG, IJzerman MJ, Zuidema SU. Psychotropic drug prescriptions in Western European nursing homes. Int Psychogeriatr. 2016;28(11):1775\u201390.","journal-title":"Int Psychogeriatr"},{"key":"6206_CR17","doi-asserted-by":"crossref","unstructured":"Van Der Spek K, Gerritsen DL, Smalbrugge M, Nelissen-Vrancken MHJMG, Wetzels RB, Smeets CHW, et al. Only 10% of The psychotropic drug use for neuropsychiatric symptoms in patients with dementia is fully appropriate. The PROPER I-study. Int Psychogeriatr. 2016;28(10):1589\u201395.","DOI":"10.1017\/S104161021600082X"},{"issue":"3","key":"6206_CR18","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1017\/S1041610209008916","volume":"21","author":"RM Nijk","year":"2009","unstructured":"Nijk RM, Zuidema SU, Koopmans RTCM. Prevalence and correlates of psychotropic drug use in Dutch nursing-home patients with dementia. Int Psychogeriatr. 2009;21(3):485\u201393.","journal-title":"Int Psychogeriatr"},{"key":"6206_CR19","doi-asserted-by":"crossref","unstructured":"Bednarczyk E, Cook S, Brauer R, Garfield S. Stakeholders\u2019 views on the use of psychotropic medication in older people: a systematic review. Age and Ageing. 2022;51(3):afac060.","DOI":"10.1093\/ageing\/afac060"},{"issue":"2","key":"6206_CR20","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1002\/pds.4142","volume":"26","author":"KH Halvorsen","year":"2017","unstructured":"Halvorsen KH, Selb\u00e6k G, Ruths S. Trends in potentially inappropriate medication prescribing to nursing home patients: comparison of three cross-sectional studies. Pharmacoepidemiol Drug Saf. 2017;26(2):192\u2013200.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"6206_CR21","doi-asserted-by":"publisher","first-page":"e2761","DOI":"10.1016\/j.jamda.2017.12.100","volume":"19","author":"EG Birkenh\u00e4ger-Gillesse","year":"2018","unstructured":"Birkenh\u00e4ger-Gillesse EG, Kollen BJ, Achterberg WP, Boersma F, Jongman L, Zuidema SU. Effects of psychosocial interventions for behavioral and psychological symptoms in dementia on the prescription of psychotropic drugs: a systematic review and meta-analyses. J Am Med Dir Assoc. 2018;19(3):e2761\u20139.","journal-title":"J Am Med Dir Assoc"},{"issue":"7","key":"6206_CR22","doi-asserted-by":"publisher","first-page":"e5311","DOI":"10.1016\/j.jamda.2014.04.007","volume":"15","author":"SA Zwijsen","year":"2014","unstructured":"Zwijsen SA, Smalbrugge M, Eefsting JA, Twisk JWR, Gerritsen DL, Pot AM, et al. Coming to grips with challenging behavior: A cluster randomized controlled trial on the effects of a multidisciplinary care program for challenging behavior in dementia. J Am Med Dir Assoc. 2014;15(7):e5311\u201310.","journal-title":"J Am Med Dir Assoc"},{"key":"6206_CR23","doi-asserted-by":"crossref","unstructured":"Pieper MJC, Francke AL, Van Der Steen JT, Scherder EJA, Twisk JWR, Kovach CR, et al. Effects of a Stepwise multidisciplinary intervention for challenging behavior in advanced dementia: A cluster randomized controlled trial. J Am Geriatr Soc. 2016;64(2):261\u20139.","DOI":"10.1111\/jgs.13868"},{"key":"6206_CR24","doi-asserted-by":"crossref","unstructured":"Van Der Spek K, Koopmans RTCM, Smalbrugge M, Nelissen-Vrancken MHJMG, Wetzels RB, Smeets CHW, et al. The effect of biannual medication reviews on the appropriateness of psychotropic drug use for neuropsychiatric symptoms in patients with dementia: A randomised controlled trial. Age Ageing. 2018;47(3):430\u20137.","DOI":"10.1093\/ageing\/afy001"},{"issue":"1","key":"6206_CR25","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jagp.2017.05.015","volume":"26","author":"B Lichtwarck","year":"2018","unstructured":"Lichtwarck B, Selbaek G, Kirkevold \u00d8, Rokstad AMM, Benth J\u0160, Lindstr\u00f8m JC, et al. Targeted interdisciplinary model for evaluation and treatment of neuropsychiatric symptoms: A cluster randomized controlled trial. Am J Geriatric Psychiatry. 2018;26(1):25\u201338.","journal-title":"Am J Geriatric Psychiatry"},{"key":"6206_CR26","doi-asserted-by":"crossref","unstructured":"Pasina L, Marengoni A, Ghibelli S, Suardi F, Djade CD, Nobili A, et al. A Multicomponent Intervention to Optimize Psychotropic Drug Prescription in Elderly Nursing Home Residents: An Italian Multicenter, Prospective, Pilot Study. Drugs Aging. 2016;33(2):143\u20139.","DOI":"10.1007\/s40266-015-0336-z"},{"key":"6206_CR27","doi-asserted-by":"crossref","unstructured":"Shaw C, Williams KN, Perkhounkova Y. Educating nursing home staff in dementia sensitive communication: impact on antipsychotic medication use. J Am Med Dir Assoc. 2018;19(12):1129\u201332.","DOI":"10.1016\/j.jamda.2018.09.030"},{"issue":"8","key":"6206_CR28","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1017\/S1041610217000084","volume":"29","author":"T Jessop","year":"2017","unstructured":"Jessop T, Harrison F, Cations M, Draper B, Chenoweth L, Hilmer S, et al. Halting antipsychotic use in Long-Term care (HALT): A single-arm longitudinal study aiming to reduce inappropriate antipsychotic use in long-term care residents with behavioral and psychological symptoms of dementia. Int Psychogeriatr. 2017;29(8):1391\u2013403.","journal-title":"Int Psychogeriatr"},{"issue":"9","key":"6206_CR29","first-page":"398","volume":"209","author":"JL Westbury","year":"2018","unstructured":"Westbury JL, Gee P, Ling T, Brown DT, Franks KH, Bindoff I, et al. RedUSe: reducing antipsychotic and benzodiazepine prescribing in residential aged care facilities. MJA. 2018;209(9):398\u2013402.","journal-title":"MJA"},{"key":"6206_CR30","doi-asserted-by":"crossref","unstructured":"Lichtwarck B, Myhre J, Selbaek G, Kirkevold \u00d8, Rokstad AMM, Benth J\u0160, et al. TIME to reduce agitation in persons with dementia in nursing homes. A process evaluation of a complex intervention. BMC Health Serv Res. 2019.","DOI":"10.1186\/s12913-019-4168-0"},{"key":"6206_CR31","doi-asserted-by":"crossref","unstructured":"Gerritsen DL, De Vries E, Smalbrugge M, Smeets CHW, Van Der Spek K, Zuidema SU, et al. Implementing a multidisciplinary psychotropic medication review among nursing home residents with dementia: A process evaluation. Int Psychogeriatr. 2021;33(9):933\u201345.","DOI":"10.1017\/S1041610219000577"},{"issue":"1","key":"6206_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1745-6215-15-302","volume":"15","author":"SA Zwijsen","year":"2014","unstructured":"Zwijsen SA, Smalbrugge M, Eefsting JA, Gerritsen DL, Hertogh CMPM, Pot AM. Grip on challenging behavior: process evaluation of the implementation of a care program. Trials. 2014;15(1):1\u201311.","journal-title":"Trials"},{"key":"6206_CR33","doi-asserted-by":"crossref","unstructured":"Pieper MJC, Achterberg WP, van der Steen JT, Francke AL. Implementation of a stepwise, multidisciplinary intervention for pain and challenging behaviour in dementia (STA OP!): A process evaluation. Int J Integr Care. 2018;18(3):15.","DOI":"10.5334\/ijic.3973"},{"key":"6206_CR34","doi-asserted-by":"crossref","unstructured":"Groot Kormelinck CM, Janus SIM, Smalbrugge M, Gerritsen DL, Zuidema SU. Systematic review on barriers and facilitators of complex interventions for residents with dementia in long-term care. Int Psychogeriatr. 2021;33(9):873\u201389.","DOI":"10.1017\/S1041610220000034"},{"issue":"4","key":"6206_CR35","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1002\/gps.4014","volume":"29","author":"SA Zwijsen","year":"2014","unstructured":"Zwijsen SA, Kabboord A, Eefsting JA, Hertogh CMPM, Pot AM, Gerritsen DL, et al. Nurses in distress? An explorative study into the relation between distress and individual neuropsychiatric symptoms of people with dementia in nursing homes. Int J Geriatr Psychiatry. 2014;29(4):384\u201391.","journal-title":"Int J Geriatr Psychiatry"},{"key":"6206_CR36","doi-asserted-by":"publisher","unstructured":"Corneg\u00e9-Blokland E, Kleijer BC, Hertogh CMPM, Van Marum RJ. Reasons to prescribe antipsychotics for the behavioral symptoms of dementia: A Survey in dutch nursing homes among physicians, nurses, and family caregivers. J Am Med Dir Assoc [Internet]. 2012;13(1):80.e1-80.e6. Available from: https:\/\/doi.org\/10.1016\/j.jamda.2010.10.004","DOI":"10.1016\/j.jamda.2010.10.004"},{"issue":"2","key":"6206_CR37","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.eurger.2014.06.003","volume":"6","author":"E Cabrera","year":"2015","unstructured":"Cabrera E, Sutcliffe C, Verbeek H, Saks K, Soto-Martin M, Meyer G, et al. Non-pharmacological interventions as a best practice strategy in people with dementia living in nursing homes. A systematic review. Eur Geriatr Med. 2015;6(2):134\u201350.","journal-title":"Eur Geriatr Med"},{"issue":"5\/6","key":"6206_CR38","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1111\/jocn.13522","volume":"26","author":"T Quasdorf","year":"2017","unstructured":"Quasdorf T, Riesner C, Dichter MN, Dortmann O, Bartholomeyczik S, Halek M. Implementing dementia care mapping to develop person-centred care: results of a process evaluation within the Leben- QD II trial. J Clin Nurs. 2017;26(5\/6):751\u201365.","journal-title":"J Clin Nurs"},{"key":"6206_CR39","doi-asserted-by":"publisher","unstructured":"Thompson Coon J, Abbott R, Rogers M, Whear R, Pearson S, Lang I et al. Interventions to Reduce Inappropriate Prescribing of Antipsychotic Medications in People With Dementia Resident in Care Homes: A Systematic Review. J Am Med Dir Assoc [Internet]. 2014;15(10):706\u201318. Available from: https:\/\/doi.org\/10.1016\/j.jamda.2014.06.012","DOI":"10.1016\/j.jamda.2014.06.012"},{"key":"6206_CR40","first-page":"1","volume":"4","author":"R Baker","year":"2015","unstructured":"Baker R, Camosso-Stefinovic J, Gillies C, Shaw EJ, Cheater F, Flottorp S, et al. Tailored interventions to address determinants of practice (Review). Cochrane Database Syst Reviews. 2015;4:1\u2013118.","journal-title":"Cochrane Database Syst Reviews."},{"key":"6206_CR41","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.ijnurstu.2012.09.010","volume":"50","author":"P Craig","year":"2013","unstructured":"Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M, et al. Developing and evaluating complex interventions: the new medical research Council guidance. Int J Nurs Stud. 2013;50:587\u201392.","journal-title":"Int J Nurs Stud"},{"issue":"374","key":"6206_CR42","first-page":"1","volume":"2021","author":"K Skivington","year":"2018","unstructured":"Skivington K, Matthews L, Simpson SA, Craig P, Baird J, Blazeby JM, et al. A new framework for developing and evaluating complex interventions: Update of Medical Research Council guidance. The BMJ. 2018;2021(374):1\u201311.","journal-title":"The BMJ."},{"issue":"4","key":"6206_CR43","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1080\/13607860903586144","volume":"14","author":"V Lawrence","year":"2010","unstructured":"Lawrence V, Banerjee S. Improving care in care homes: A qualitative evaluation of the Croydon care home support team. Aging Ment Health. 2010;14(4):416\u201324.","journal-title":"Aging Ment Health"},{"issue":"1","key":"6206_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1748-5908-4-69","volume":"4","author":"LK Leykum","year":"2009","unstructured":"Leykum LK, Pugh JA, Lanham HJ, Harmon J, McDaniel RR. Implementation research design: integrating participatory action research into randomized controlled trials. Implement Sci. 2009;4(1):1\u20138.","journal-title":"Implement Sci"},{"key":"6206_CR45","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1186\/s12888-019-2291-4","volume":"19","author":"CM Groot Kormelinck","year":"2019","unstructured":"Groot Kormelinck CM, Van Teunenbroek CF, Kollen BJ, Reitsma M, Gerritsen DL, Smalbrugge M, et al. Reducing inappropriate psychotropic drug use in nursing home residents with dementia: protocol for participatory action research in a stepped-wedge cluster randomized trial. BMC Psychiatry. 2019;19:298.","journal-title":"BMC Psychiatry"},{"key":"6206_CR46","doi-asserted-by":"publisher","unstructured":"Hopewell S, Chan AW, Collins GS, Hr\u00f3bjartsson A, Moher D, Schulz KF. CONSORT 2025 Statement: updated guideline for reporting randomised trials. BMJ [Internet]. 2025 [cited 2025 Jun 20];389:e081123. Available from: https:\/\/doi.org\/10.1136\/bmj-2024-081123","DOI":"10.1136\/bmj-2024-081123"},{"key":"6206_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2288-6-54","volume":"6","author":"CA Brown","year":"2006","unstructured":"Brown CA, Lilford RJ. The stepped wedge trial design: A systematic review. BMC Med Res Methodol. 2006;6:1\u20139.","journal-title":"BMC Med Res Methodol"},{"key":"6206_CR48","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1016\/j.jamda.2017.05.013","volume":"18","author":"RTCM Koopmans","year":"2017","unstructured":"Koopmans RTCM, Pellegrom M, van der Geer ER. The Dutch move beyond the concept of nursing home physician specialists. J Am Med Dir Assoc. 2017;18:746\u20139.","journal-title":"J Am Med Dir Assoc"},{"key":"6206_CR49","unstructured":"European Commission. The European qualifications framework for lifelong learning (EQF). Office for Official Publications of the European Communities; 2008. p. 1\u201320."},{"issue":"414","key":"6206_CR50","first-page":"1","volume":"21","author":"CM Groot Kormelinck","year":"2021","unstructured":"Groot Kormelinck CM, van Teunenbroek CF, Zuidema SU, Smalbrugge M, Gerritsen DL. Process evaluation of a tailored intervention to reduce inappropriate psychotropic drug use in nursing home residents with dementia. BMC Geriatr. 2021;21(414):1\u201314.","journal-title":"BMC Geriatr"},{"key":"6206_CR51","first-page":"23","volume-title":"Nordiska l\u00e4kemedelsn\u00e4mden. Guidelines for ATC classification","author":"WHO Collaborating Centre for Drug Statistics Methodology","year":"1993","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology. Nordiska l\u00e4kemedelsn\u00e4mden. Guidelines for ATC classification. 4th ed. Oslo: WHO Collaborating Centre for Drug Statistics Methodology; 1993. pp. 23\u2013185.","edition":"4"},{"key":"6206_CR52","doi-asserted-by":"crossref","unstructured":"Van Der Spek K, Gerritsen DL, Smalbrugge M, Nelissen-Vrancken MHJMG, Wetzels RB, Smeets CHW et al. A reliable and valid index was developed to measure appropriate psychotropic drug use in dementia. J Clin Epidemiol. 2015;68(8):903-12.","DOI":"10.1016\/j.jclinepi.2015.03.012"},{"issue":"6","key":"6206_CR53","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1111\/j.1365-2753.2011.01758.x","volume":"18","author":"R Luo","year":"2012","unstructured":"Luo R, Scullin C, Mullan AMP, Scott MG, McElnay JC. Comparison of tools for the assessment of inappropriate prescribing in hospitalized older people. J Eval Clin Pract. 2012;18(6):1196\u2013202.","journal-title":"J Eval Clin Pract"},{"key":"6206_CR54","unstructured":"Kat MG, de Jonghe JFM, Aalten P, Kalisvaart CJ, Dr\u00f6es RM, Verhey FRJ. Neuropsychiatric symptoms of dementia: psychometric aspects of the Dutch neuropsychiatric inventory (NPI). Tijdschr Gerontol Geriatr. 2002;33(4):150\u20135."},{"issue":"12","key":"6206_CR55","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1212\/WNL.44.12.2308","volume":"44","author":"JL Cummings","year":"1994","unstructured":"Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The neuropsychiatric inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994;44(12):2308\u201314.","journal-title":"Neurology"},{"issue":"8","key":"6206_CR56","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1023\/B:EJEP.0000036572.00663.f2","volume":"19","author":"JWR Twisk","year":"2004","unstructured":"Twisk JWR. Longitudinal data analysis. A comparison between generalized estimating equations and random coefficient analysis. Eur J Epidemiol. 2004;19(8):769\u201376.","journal-title":"Eur J Epidemiol"},{"key":"6206_CR57","unstructured":"Zuidema SU, Koopmans RTCM, Schols JMGA, Achterberg WP, Hertogh CMPM. Trends in psychofarmacagebruik bij pati\u00ebnten met dementie in Nederlandse verpleeghuizen, periode 2003\u20132011. Tijdschrift voor ouderengeneeskunde. 2015."},{"issue":"10","key":"6206_CR58","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1017\/S1041610211001438","volume":"23","author":"SU Zuidema","year":"2011","unstructured":"Zuidema SU, De Jonghe JFM, Verhey FRJ, Koopmans RTCM. Psychotropic drug prescription in nursing home patients with dementia: influence of environmental correlates and staff distress on physicians\u2019 prescription behavior. Int Psychogeriatr. 2011;23(10):1632\u20139.","journal-title":"Int Psychogeriatr"},{"issue":"6","key":"6206_CR59","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1080\/13607863.2021.1922601","volume":"26","author":"DA Wiggin","year":"2022","unstructured":"Wiggin DA, Timmons S, Rukundo A, Walsh KA. Improving the appropriateness of psychotropic prescribing for nursing home residents with dementia: an overview of reviews. Aging Ment Health. 2022;26(6):1087\u201394.","journal-title":"Aging Ment Health"},{"key":"6206_CR60","first-page":"1","volume":"368","author":"H Moustgaard","year":"2020","unstructured":"Moustgaard H, Clayton GL, Jones HE, Boutron I, J\u00f8rgensen L, Laursen DLT, et al. Impact of blinding on estimated treatment effects in randomised clinical trials: Meta-epidemiological study. BMJ. 2020;368:1\u20134.","journal-title":"BMJ"},{"key":"6206_CR61","doi-asserted-by":"crossref","unstructured":"Gilissen J, Pivodic L, Gastmans C, Vander Stichele R, Deliens L, Breuer E, et al. How to achieve the desired outcomes of advance care planning in nursing homes: A theory of change. BMC Geriatr. 2018;18(1):47.","DOI":"10.1186\/s12877-018-0723-5"},{"issue":"8","key":"6206_CR62","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1111\/jgs.12939","volume":"62","author":"YJ Wei","year":"2014","unstructured":"Wei YJ, Simoni-Wastila L, Zuckerman IH, Huang TYJ, Brandt N, Moyo P, et al. Quality of psychopharmacological medication prescribing and mortality in medicare beneficiaries in nursing homes. J Am Geriatr Soc. 2014;62(8):1490\u2013504.","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"6206_CR63","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1080\/01612840.2019.1635669","volume":"41","author":"C Neville","year":"2020","unstructured":"Neville C, Beccaria L, Carey M. Withdrawal versus continuation of Long-Term antipsychotic drug use for behavioural and psychological symptoms in older people with dementia. Issues Ment Health Nurs. 2020;41(2):176\u20137.","journal-title":"Issues Ment Health Nurs"},{"key":"6206_CR64","doi-asserted-by":"crossref","unstructured":"McCleery J, Sharpley AL. Pharmacotherapies for sleep disturbances in dementia. Cochrane Database Syst Rev. 2020;11(11):CD009178.","DOI":"10.1002\/14651858.CD009178.pub4"}],"container-title":["BMC Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-025-06206-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12877-025-06206-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-025-06206-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T12:18:16Z","timestamp":1757333896000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgeriatr.biomedcentral.com\/articles\/10.1186\/s12877-025-06206-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,2]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6206"],"URL":"https:\/\/doi.org\/10.1186\/s12877-025-06206-y","relation":{},"ISSN":["1471-2318"],"issn-type":[{"type":"electronic","value":"1471-2318"}],"subject":[],"published":{"date-parts":[[2025,8,2]]},"assertion":[{"value":"31 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Legal representatives of eligible residents were approached in writing to inform them about the study. Written informed consent was obtained for all participants. The Medical Ethics Review Board of the University Medical Centre Groningen has assessed the study and concluded that this non-invasive study did not constitute clinical research with human subjects, as meant by the Dutch Medical Research Involving Human Subjects Act (METC decision: METc 2016.094). The study was conducted in accordance with the declaration of Helsinki and the General Data Protection Regulation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"581"}}